Dasotraline
| Dasotraline | |
|---|---|
| Salts [] | |
|---|---|
| Dasotraline hydrochloride | |
| Molecular structure via molpic based on CDK |
| Rotamer [] | |
|---|---|
| Conformer structure via 3Dmol.js |
| Physical properties [] | |
|---|---|
| Molecular mass | 292.2 g/mol [1] |
| Predicted LogP | 4.3 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C16H15Cl2N [1] |
| IUPAC name | (1R,4S)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-amine [1] |
| SMILES | C1C[C@H](C2=CC=CC=C2[C@@H]1C3=CC(=C(C=C3)Cl)Cl)N [1] |
| InChI | InChI=1S/C16H15Cl2N/c17-14-7-5-10(9-15(14)18)11-6-8-16(19)13-4-2-1-3-12(11)13/h1-5,7,9,11,16H,6,8,19H2/t11-,16+/m0/s1 [1] |
| InChIKey | SRPXSILJHWNFMK-MEDUHNTESA-N [1] |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 47 – 77 hours |
Dasotraline (also known as (1R,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-amine, (1R,4S)-trans-Norsertraline, Norsertraline, (1R,4S)-trans-, Dasotralina, SEP-225289, Dtxsid20217855, Sep-225,289, 1-Naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-, (1r,4s)-, dasotralinum or Dtxcid70140346) is a serotonin reuptake inhibitor substance of the benzylamine class.
Chemistry
Salts []
Dasotraline is typically found in the form of its hydrochloride salt.
Stereochemistry []
Dasotraline is a absolute mixture.
Subjective effects []
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 9947999, Dasotraline. Accessed May 9, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/9947999
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Dasotraline. UNII: 4D28EY0L5T. Global Substance Registration System. Accessed May 9, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/4D28EY0L5T